FindTrial
Sign In

Herbal medicine for metabolic syndrome due to olanzapine in hospitalized patients with schizophrenia:a retrospective controlled study

Herbal medicine for metabolic syndrome due to olanzapine in hospitalized patients with schizophrenia:a retrospective controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-16008061
Enrollment
Unknown
Registered
2016-03-07
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

study goup:TCM combinate with olanzapine
contral group:olanzapine

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 77 Years

Inclusion criteria

Inclusion criteria: 1. had a diagnosis of schizophrenia according to DSM-IV; 2. The severity of the symptoms is moderate or severe; 3. Hospitalized patients; and 4. Absence of brain and/or severe physical diseases.

Exclusion criteria

Exclusion criteria: (1)In pregnancybrain and other severe medical conditions; (2) psychoactive substance abuse.

Design outcomes

Primary

MeasureTime frame
weight;ALT;TG;blood sugar;—

Secondary

MeasureTime frame
blood pressure;CCr;—

Countries

China

Contacts

Public ContactZHANG,ZHANGJIN

The University of Hong Kong

zhangzj@hku.hk+852 62064782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026